Search

for
Search:

GlossaryInjectable Platelet-Rich Fibrin

regenerative treatment using concentrated platelets and fibrin from blood

Injectable Platelet-Rich Fibrin (i-PRF) is a regenerative treatment derived from a patient's own blood, which is processed to concentrate platelets and fibrin. This injectable substance is rich in growth factors and cytokines, promoting tissue healing and regeneration, and is commonly used in medical and aesthetic procedures, including hair restoration and wound healing.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 967 results

Injectable Platelet-Rich Fibrin: The Newest Biomaterial and Its Use in Various Dermatological Conditions in Our Practice: A Case Series

research Injectable Platelet-Rich Fibrin: The Newest Biomaterial and Its Use in Various Dermatological Conditions in Our Practice: A Case Series

23 citations, September 2020 in “Journal of Cosmetic Dermatology”

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

research Injectable Platelet-Rich Fibrin with Stem Cells for the Treatment of Alopecia: A Report of Three Patients

18 citations, January 2019 in “International journal of trichology”

The treatment improved hair growth in three patients with alopecia.

research Injectable Platelet Rich Fibrin Facilitates Hair Follicle Regeneration by Promoting Human Dermal Papilla Cell Proliferation, Migration, and Trichogenic Inductivity

2 citations, October 2021 in “Experimental Cell Research”

Injectable platelet-rich fibrin helps hair growth by boosting key cell functions.

research A Study on the Efficacy of Injectable Platelet Rich Fibrin for Androgenetic Alopecia in Males

December 2024 in “Research Journal of Medical Sciences”

Injectable Platelet Rich Fibrin effectively improves hair growth in males with hair loss.

Comparing the Efficacy of Injectable Platelet-Rich Fibrin (I-PRF) with Platelet-Rich Plasma (PRP) in the Treatment of Androgenic Alopecia

research Comparing the Efficacy of Injectable Platelet-Rich Fibrin (I-PRF) with Platelet-Rich Plasma (PRP) in the Treatment of Androgenic Alopecia

December 2024 in “Biological and Clinical Sciences Research Journal”

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

View more "injectable platelet-rich fibrin" in research →

Community Join

5 / 39 results

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 42 upvotes 5 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community Went from almost balding to some this!

in Progress Pictures 498 upvotes 1 year ago

A user successfully regrew hair after nearly going bald by using oral finasteride, topical minoxidil, plasma injections, and mesotherapy over 9 months. They plan to try derma rolling and have an alarm set for taking medication, noting increased sexual drive as a side effect.

community DIY Dutasteride Mesotherapy ....Part 3 ....How to Compound injectable dutasteride

in Finasteride/Dutasteride 6 upvotes 3 years ago

The conversation is about DIY Dutasteride mesotherapy for hair loss, focusing on creating an injectable treatment to target the scalp and limit side effects. The user seeks feedback on enhancing the treatment with additional ingredients.

community Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments

in Treatment 39 upvotes 3 months ago

AMP-303, a new injectable treatment for androgenetic alopecia, showed promising results in increasing hair count and density with minimal side effects. The treatment demonstrated significant hair regrowth and durability, offering new hope for those with hair loss.

community Any updates on upcoming hair loss medication?

in Research/Science 18 upvotes 7 months ago

The conversation discusses updates on hair loss treatments, specifically GT20029, PP405, and a rumored injectable peptide from UT. GT20029 is seen as a promising treatment expected within 5-7 years.

View more "injectable platelet-rich fibrin" in community →